» Articles » PMID: 31339925

The Prognostic Value of NIRS in Preterm Infants with (suspected) Late-onset Sepsis in Relation to Long Term Outcome: A Pilot Study

Overview
Journal PLoS One
Date 2019 Jul 25
PMID 31339925
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Late-onset sepsis is frequently seen in preterm infants and is associated with poor neurodevelopmental outcome. White matter damage is proposed as substrate of poor outcome, with contributing factors as regional hypoxia and effects of cytokines on oligodendrocytes. We investigated the relation between cerebral oxygenation during (suspected) late-onset sepsis and neurodevelopmental outcome. Prospective cohort study, including preterm infants (gestational age <32 weeks and/or birthweight <1500 grams) with (suspected) late-onset sepsis underwent NIRS registration during the first 72 hours of suspected late-onset sepsis. At two years corrected age neurodevelopment was scored using the Bayley Scales of Infant Development-II. Thirty-two infants were included. Twenty-seven infants were identified with proven late-onset sepsis and five infants had clinical sepsis without positive blood culture. In this study, late-onset sepsis was predominantly caused by coagulase negative staphylococci (CoNS) (72%). All NIRS values were within normal limits. No association was found between NIRS and impaired neurodevelopmental outcome (n = 4) at corrected age two years: composite cognitive score 105 (80-115), composite motor score 103 (82-118) (median and range). In this pilot study, late-onset sepsis (predominantly caused by CoNS with a relatively mild clinical course), was not associated with aberrant NIRS values, nor with impaired neurodevelopmental outcome. Further research might establish our findings and elucidate effects of other micro-organisms on cerebral perfusion.

Citing Articles

Assessment of hemodynamic dysfunction in septic newborns by functional echocardiography: a systematic review.

Pugnaloni F, De Rose D, Kipfmueller F, Patel N, Ronchetti M, Dotta A Pediatr Res. 2024; 95(6):1422-1431.

PMID: 38245631 DOI: 10.1038/s41390-024-03045-2.


Look Who's Talking: Host and Pathogen Drivers of Virulence in Neonatal Sepsis.

Joubert I, Otto M, Strunk T, Currie A Int J Mol Sci. 2022; 23(2).

PMID: 35055041 PMC: 8775791. DOI: 10.3390/ijms23020860.


Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.

Xie Z, Lin B, Jia X, Su T, Wei Y, Tang J Histol Histopathol. 2021; 36(11):1179-1187.

PMID: 34528700 DOI: 10.14670/HH-18-375.


Vital signs as physiomarkers of neonatal sepsis.

Sullivan B, Fairchild K Pediatr Res. 2021; 91(2):273-282.

PMID: 34493832 DOI: 10.1038/s41390-021-01709-x.


The Behavioral Problems in 2.5-5 Years Old Children Linked with Former Neonatal/Infantile Surgical Parameters.

Rugyte D, Sirvinskiene G, Kregzdyte R Children (Basel). 2021; 8(5).

PMID: 34065274 PMC: 8160720. DOI: 10.3390/children8050423.

References
1.
Plomgaard A, Alderliesten T, van Bel F, Benders M, Claris O, Cordeiro M . No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life. Acta Paediatr. 2018; 108(2):275-281. PMC: 6585779. DOI: 10.1111/apa.14463. View

2.
Glass H, Bonifacio S, Chau V, Glidden D, Poskitt K, Barkovich A . Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics. 2008; 122(2):299-305. DOI: 10.1542/peds.2007-2184. View

3.
Adams-Chapman I . Long-term impact of infection on the preterm neonate. Semin Perinatol. 2012; 36(6):462-70. DOI: 10.1053/j.semperi.2012.06.009. View

4.
Bode M, DEugenio D, Mettelman B, Gross S . Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infants. J Dev Behav Pediatr. 2014; 35(9):570-5. DOI: 10.1097/DBP.0000000000000110. View

5.
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M . Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015; 350:g7635. PMC: 4283997. DOI: 10.1136/bmj.g7635. View